• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2100018 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2021-01-11 甘李药业股份有限公司 Gan & Lee Pharmaceuticals In Review 2022-01-19 view
CYSB2100019 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2021-01-11 甘李药业股份有限公司 Gan & Lee Pharmaceuticals In Review 2022-01-19 view
JYSB2000606 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-12-10 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-11-16 view
JYSB2000610 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-12-10 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-11-16 view
JYSB2000609 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-12-10 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-11-16 view
JYSB2000608 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-12-10 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-11-16 view
CXSS2000052 甘精胰岛素注射液 insulin glargine Injection Biological Products(3.3) New Drug Application 2020-10-15 宜昌东阳光长江药业股份有限公司 Yichang HEC Changjiang Pharmaceutical Co Ltd Certificate Issued 2021-11-02 view
JYSB2000607 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-12-10 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2021-10-21 view
CYSB2000380 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-12-23 赛诺菲(北京)制药有限公司 Sanofi (Beijing) Pharmaceuticals Co Ltd Certificate Issued 2021-10-18 view
CYSB2000379 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-12-23 赛诺菲(北京)制药有限公司 Sanofi (Beijing) Pharmaceuticals Co Ltd Certificate Issued 2021-10-18 view
CYSB2000405 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2021-01-01 通化东宝药业股份有限公司 Tonghua Dongbao Pharmaceutical Co Ltd Certificate Issued 2021-08-24 view
JXSS2000064 甘精胰岛素注射液 insulin glargine Injection Biological Products(3.3) Import Drug Application 2020-12-23 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd In Review 2021-05-09 view
JYSB2100052 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2021-02-23 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2021-02-22 view
JYSB2100023 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2021-01-19 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2021-01-18 view
JYSB2100022 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2021-01-19 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd In Review 2021-01-18 view
JYSB2000624 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-12-14 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Filed 2020-12-25 view
JXSS2000065 甘精胰岛素注射液 insulin glargine Injection Biological Products(3.3) Import Drug Application 2020-12-23 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd In Review 2020-12-22 view
JXSS1900030 甘精胰岛素注射液 insulin glargine Injection Biological Products Import Drug Application 2019-06-12 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2020-09-04 view
JYSB2000253 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-06-18 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Filed 2020-06-19 view
JYSB2000254 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2020-06-18 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Filed 2020-06-19 view